APOBEC3B and neoplasm: Therefore, we used an immunogenic KRASG12D-driven GEMM derived cell line (KPARG12D) which overexpresses APOBEC3B, a single stranded DNA deaminase that induces high mutational burden and strong anti-tumor responses, resulting in a model that is overall more faithful of human disease [47].